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p38 Mitogen-Activated Protein Kinase: A Novel Modulator of
Hyperpolarization-Activated Cyclic Nucleotide-Gated
Channels and Neuronal Excitability
Patricia Wynne
Graduate Program in Neurobiology, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, Massachusetts
01605
Review of Poolos et al. (http://www.jneurosci.org/cgi/content/full/26/30/7995)
Hyperpolarization-activated cyclic nucleo-
tide-gated (HCN) channels are permeable
to Na/K and underlie the inwardly
rectifying current termed Ih, I(f), or Iq
(Santoro and Tibbs, 1999). Regulated by
voltage and the binding of ligands, there
are four HCN isoforms that vary in their
activation kinetics. These currents con-
tribute to the control of excitability, plas-
ticity, and rhythmicity in cardiac cells and
neurons throughout the CNS. In hip-
pocampal pyramidal neurons, cAMP-
insensitive Ih currents affect input resis-
tance (IR) and temporal summation (TS)
of EPSPs, thereby influencing dendritic
synaptic integration.Thekinetics anddistri-
bution of Ih are the principal factors influ-
encing temporal summation and subse-
quent synchronizationofCA1hippocampal
neurons (Magee, 1999). Recent studies
have implicated these channels in learning
and memory (Nolan et al., 2003) and the
pathophysiology of diseases involving
neuronal excitability such as epilepsy
(Ludwig et al., 2003). Based on data from
excised patches of exogenously expressed
HCN1orHCN2 channels, which display a
hyperpolarized shift in voltage-dependent
activation independent of cAMP activity,
Poolos et al. (2006) hypothesized that alter-
native proteins associated with the mem-
brane patch contribute to the regulation of
Ih activity. To determine modulators of
HCN activity, in their recent paper in The
Journal of Neuroscience, Poolos et al. (2006)
identify p38 mitogen-activated protein
kinase (MAPK) through computational
analysis and examined its effects on Ih.
The authors initially screened and
identified 12 potential kinase modulators
of HCN1 and HCN2 using the Scansite
software tool [Poolos et al. (2006), their
Table 1 (http://www.jneurosci.org/cgi/
content/full/26/30/7995/T1)]. Based on
the highest level of stringency and likeli-
hood of interaction with HCN1 and
HCN2, the authors chose to examine the
modulatory effect of p38 MAPK. Using
adult rat hippocampal slices, the authors
examined Ih in CA1 pyramidal dendrites
and pyramidal-like principal (PLP) neu-
rons. Although biocytin fills of these neu-
rons showed a similar apical dendritic
morphology [Poolos et al. (2006), their
Fig. 1A,B (http://www.jneurosci.org/cgi/
content/full/26/30/7995/F1)], these two
cell types had opposite somatodendritic Ih
distributions. CA1 neurons had a high
dendritic and low somatic Ih density,
whereas PLP neurons had a high somatic
Ih density, allowing the authors to exam-
ine Ih in somatic recordings. In both cell
types, macroscopic Ih currents were re-
corded in cell-attached patch-clamp
mode at various hyperpolarizing poten-
tials, and the activation kinetics were fit-
ted with a double exponential. The bio-
physical properties of Ih currents were
similar in maximal density, voltage-
dependent activation [Poolos et al. (2006),
their Fig. 1C (http://www.jneurosci.org/cgi/
content/full/26/30/7995/F1)] and activa-
tion kinetics [Poolos et al. (2006), their Fig.
1D (http://www.jneurosci.org/cgi/content/
full/26/30/7995/F1)]. The fast kinetics of
these channels suggest that CA1 dendritic
andPLP somatic Ih currents are attributable
to the HCN1 subtype. Also consistent with
the HCN1 phenotype, Ih activation in CA1
dendrites was unaltered after application of
a cAMP analog [Poolos et al. (2006), their
Fig. 2E (http://www.jneurosci.org/cgi/
content/full/26/30/7995/F2)].
To test whether modulation of p38
MAPKaffected Ih, the authors inhibitedp38
MAPK with two specific cell-permeable
inhibitors, 4-[5-(4-fluorophenyl)-2-(4-
[(S)-methylsulfinyl]phenyl)-3H-imidazol-
4-yl]pyridine (SB203580) and SB202190
[4-(4-fluorophenyl)-2-(4-hydroxyphen-
yl)-5-(4-pyridyl)1H-imidazole]. In both
cell types, MAPK inhibition resulted in a
leftward shift in voltage-dependent acti-
vation, indicating that more hyperpolar-
ized potentials elicited Ih current (V1/2
decreased25 mV) [Poolos et al. (2006),
their Fig. 2A,B (http://www.jneurosci.
org/cgi/content/full/26/30/7995/F2)].
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Pharmacological inhibition of twoMAPK
family members, ERK 1/2 (extracellular
signal-regulated kinase 1/2) and c-Jun N-
terminal protein kinase (JNK), or an inac-
tive MAPK inhibitor analog did not affect
Ih activation [Poolos et al. (2006), their
Fig. 2C,D (http://www.jneurosci.org/cgi/
content/full/26/30/7995/F2)]. Anisomycin,
anMAPK and JNK activator, resulted in a
depolarizing shift in Ih activation of 11
mV in PLP neurons [Poolos et al. (2006),
their Fig. 2F (http://www.jneurosci.org/
cgi/content/full/26/30/7995/F2)]. The au-
thors argue that, because JNK inhibition
did not modulate Ih activation, anisomy-
cinmust act to upregulate Ih via activation
of p38 MAPK. These experiments show
that resting levels of activated MAPK dy-
namically modulate Ih activation. It
would be interesting to see whether the
effects of the antiepileptic drug lam-
otrigine, which the authorsmention shifts
Ih activation in a depolarized direction,
can be abolished by coapplication with
SB203580.
Next, the authors assessed whether IR
and TS would be altered by modulating
p38 MAPK levels. The MAPK inhibitor
SB203580 caused 72 and 85% in-
crease in IR in CA1 dendrites and PLP
neurons, consistent with a decrease in ac-
tive Ih [Poolos et al. (2006), their Fig. 4
(http://www.jneurosci.org/cgi/content/
full/26/30/7995/F4)]. Also consistent with
a decrease in Ih, SB203580 caused 16
and25% increase in the TS of a series of
EPSPs [Poolos et al. (2006), their Fig. 5
(http://www.jneurosci.org/cgi/content/full/
26/30/7995/F5)]. To determinewhether the
changes in IR and TSwere specific to Ih, the
authors blocked Ih in PLP neurons with
N-ethyl-1,2-dimethyl-6-methylimino-N-
phenyl-pyrimidin-4-amine hydrochloride
(ZD7288) which caused an increase of
162% in IR and 41% in TS. Coapplication
of SB203580 and ZD7288 caused no sig-
nificant change in IR or TS, indicating
that effects of MAPK inhibition on IR/TS
were dependent on intact Ih. Conversely,
to determine the effects of MAPK activa-
tion on IR and TS, PLP neurons were in-
tracellularly perfused with activated p38
MAPK. Consistent with an upregulation
of Ih, a decrease in IR and TSwas observed
[Poolos et al. (2006), their Fig. 6 (http://
www.jneurosci.org/cgi/content/full/26/
30/7995/F6)], further confirming the role
of p38 MAPK in modulation of voltage-
dependent activation of Ih in pyramidal
neurons.
Poolos et al. (2006) provide the first
evidence that p38 MAPK robustly regu-
lates Ih activity, shifting the number of
channels active at the resting membrane
potential and thus profoundly affecting
hippocampal neuronal excitability (illus-
trated in Fig. 1). Although it is unknown
whether p38 MAPK directly phosphory-
lates HCN channels, Poolos et al. (2006)
pave the way for such studies. Further-
more, these results identify p38 MAPK as
a potential therapeutic target for diseases
such as epilepsy and cardiac arrhythmia
in which HCN channels have been
implicated.
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Figure1. Overviewofp38MAPK regulationof Ih activationat amembranepotential (Vh ) of80mV inhippocampal neurons.
A, The majority of HCN channels remain in the closed state when p38 MAPK is pharmacologically inhibited by SB203580. B, In
contrast, at the samemembrane potential, HCN channels open when p38 MAPK is activated by anisomycin.
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